Literature DB >> 9386023

Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone.

E J Mulder1, J B Derks, G H Visser.   

Abstract

OBJECTIVES: To compare the effects of maternal betamethasone and dexamethasone administration on fetal behaviour and fetal heart rate variation.
DESIGN: A prospective randomised study of 60 women at increased risk of preterm delivery. OUTCOME MEASURES: Fetal heart rate and its variation, the incidence of fetal body and breathing movements.
SETTING: Obstetric unit, University Hospital, Utrecht, The Netherlands.
RESULTS: Following maternal betamethasone administration (day 2), fetal heart rate variation was reduced by 19% and fetal body and breathing movements by 49% and 85%, respectively. After dexamethasone treatment there was a significant increase in short term fetal heart rate variation (24%) on day 1. All values returned to baseline on day 4, indicating that no fetal deterioration had occurred during the course of the study period.
CONCLUSION: Betamethasone, with probably the greater beneficial effect, has more effects on fetal behaviour and fetal heart rate variation than dexamethasone. When assessing fetal condition, due account needs to be taken of these effects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9386023     DOI: 10.1111/j.1471-0528.1997.tb10969.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  19 in total

1.  Non-linear changes of electrocortical activity after antenatal betamethasone treatment in fetal sheep.

Authors:  M Schwab; K Schmidt; M Roedel; T Mueller; H Schubert; M A Anwar; P W Nathaniels
Journal:  J Physiol       Date:  2001-03-01       Impact factor: 5.182

Review 2.  Fetal exposure to corticosteroids: how low can we go?

Authors:  Mark J M Nijland
Journal:  J Physiol       Date:  2003-03-28       Impact factor: 5.182

3.  Effect of antenatal betamethasone treatment on microtubule-associated proteins MAP1B and MAP2 in fetal sheep.

Authors:  M Schwab; I Antonow-Schlorke; B Kühn; T Müller; H Schubert; B Walter; U Sliwka; P W Nathanielsz
Journal:  J Physiol       Date:  2001-02-01       Impact factor: 5.182

4.  Effect of Single Dose Betamethasone Administration in Pregnancy on Maternal and Newborn Parameters.

Authors:  Komal Gaur; Barna Ganguly
Journal:  J Clin Diagn Res       Date:  2017-05-01

Review 5.  Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.

Authors:  Devender Roberts; Julie Brown; Nancy Medley; Stuart R Dalziel
Journal:  Cochrane Database Syst Rev       Date:  2017-03-21

6.  Effect of maternal betamethasone administration on feto-placental vascular resistance in the mouse†.

Authors:  Lindsay S Cahill; Clare L Whitehead; Sebastian R Hobson; Greg Stortz; John C Kingdom; Ahmet Baschat; Kellie E Murphy; Lena Serghides; Christopher K Macgowan; John G Sled
Journal:  Biol Reprod       Date:  2019-10-25       Impact factor: 4.285

Review 7.  Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth.

Authors:  Fiona C Brownfoot; Caroline A Crowther; Philippa Middleton
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

8.  Glucocorticoid exposure at the dose used clinically alters cytoskeletal proteins and presynaptic terminals in the fetal baboon brain.

Authors:  Iwa Antonow-Schlorke; Matthias Schwab; Cun Li; Peter W Nathanielsz
Journal:  J Physiol       Date:  2002-11-15       Impact factor: 5.182

Review 9.  Glucocorticoids and preterm hypoxic-ischemic brain injury: the good and the bad.

Authors:  Laura Bennet; Joanne O Davidson; Miriam Koome; Alistair Jan Gunn
Journal:  J Pregnancy       Date:  2012-08-16

10.  Short-Term Effects of Dexamethasone versus Betamethasone on Ultrasonic Measures of Fetal Well-Being: Cohort from a Blinded, Randomized Trial.

Authors:  Amanda Henry; Aditi Mahajan; Caroline A Crowther; Anne Lainchbury; Lynne Roberts; Antonia W Shand; Alec W Welsh
Journal:  Fetal Diagn Ther       Date:  2021-07-28       Impact factor: 2.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.